title: Alemtuzumab and de novo pulmonary arterial hypertension: A potential association?
authors.affiliation: Pôle Pharmacie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
authors.forename: Laura
authors.initials: L
authors.lastname: Beaumier
authors.affiliation: Pôle Pharmacie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France; Facultés de Médecine et de Pharmacie, Université Grenoble Alpes, Grenoble, France.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Chanoine
authors.affiliation: Clinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
authors.forename: Boubou
authors.initials: B
authors.lastname: Camara
authors.affiliation: Facultés de Médecine et de Pharmacie, Université Grenoble Alpes, Grenoble, France; Clinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Pison
authors.affiliation: Pôle Pharmacie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France; Facultés de Médecine et de Pharmacie, Université Grenoble Alpes, Grenoble, France.
authors.forename: Pierrick
authors.initials: P
authors.lastname: Bedouch
mesh_terms: D000368:Aged; D000074323:Alemtuzumab / Q000009:adverse effects* / Q000627:therapeutic use; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced* / Q000503:physiopathology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008297:Male; D011669:Pulmonary Wedge Pressure / Q000187:drug effects*; D012307:Risk Factors
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000074323:Alemtuzumab